Omeprazole (A2845): Technical Guide for Gastric Acid Secretion and Antiulcer Research

What This Product Solves

Omeprazole, chemically designated as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a selective and potent H+,K+-ATPase inhibitor. It is widely adopted in laboratory workflows to suppress gastric acid secretion with high reproducibility, enabling robust experimental modeling of peptic ulcer disease and related gastric acid disorders. Its high specificity and 98% purity profile make it suitable for protocols where precise inhibition of proton pumps is critical, such as antiulcer activity studies and mechanistic evaluations of gastric acid secretion (Omeprazole). Omeprazole should not be used for diagnostic or medical applications, and is formulated exclusively for scientific research use.

Protocol Parameters

• assay: H+,K+-ATPase inhibition | value_with_unit: IC50 = 5.8 μM | applicability: Use for functional proton pump inhibition studies in cell-based or ex vivo gastric models | rationale: Enables consistent suppression of gastric acid secretion, facilitating antiulcer mechanism evaluation | source_type: product_spec
• assay: Histamine-induced acid formation inhibition | value_with_unit: IC50 = 0.16 μM | applicability: Apply in workflows assessing histamine-stimulated acid secretion in gastric tissue or organoid models | rationale: Supports sensitive quantification of acid suppression under physiologically relevant stimuli | source_type: product_spec
• assay: Compound solubility in DMSO | value_with_unit: ≥17.27 mg/mL | applicability: Dissolve only in DMSO for stock solution preparation; avoid water and ethanol | rationale: Ensures full solubilization for accurate dosing and reproducible experimental outcomes | source_type: product_spec
• assay: Storage conditions (solid) | value_with_unit: -20°C | applicability: Store powder at -20°C in a desiccated environment for long-term stability | rationale: Maintains compound purity and prevents degradation | source_type: product_spec
• assay: Stock solution stability | value_with_unit: Short-term only; avoid long-term solution storage | applicability: Prepare fresh solutions as needed; do not store dissolved aliquots | rationale: Minimizes risk of hydrolysis or loss of activity in solution form | source_type: product_spec

Workflow Setup and QC Checklist

For reliable and reproducible results using Omeprazole in gastric acid secretion research, follow these workflow setup and quality control (QC) measures:

• Weigh Omeprazole accurately to prepare concentrated stock (≥17.27 mg/mL) in DMSO. Avoid aqueous or ethanol-based solvents due to insolubility.
• Aliquot stock solutions immediately after preparation to minimize freeze-thaw cycles, discarding unused portions after each experiment.
• Store the solid compound at -20°C, protected from moisture and light. Confirm no signs of degradation (e.g., color change, precipitation) prior to use.
• Calibrate dosing in experimental models based on IC50 values for either general H+,K+-ATPase inhibition (5.8 μM) or histamine-induced acid suppression (0.16 μM), depending on the research objective.
• Perform functional validation of each new batch using a reference assay for proton pump inhibition, ensuring reproducibility across experiments.
• Use blue ice shipping for all incoming product to maintain compound integrity during transit, as recommended by APExBIO (Omeprazole).

For advanced protocol integration, refer to internal resources such as Optimizing Gastric Acid Secretion Research with 3-(quinolin-4-ylmethylamino)..., which provides stepwise enhancements and troubleshooting tips for complex disease model workflows.

Common Failure Modes and Fixes

• Poor solubility in selected solvent: Omeprazole is only soluble at high concentrations in DMSO. Attempting to dissolve in water or ethanol will result in incomplete dissolution and inaccurate dosing. Always use DMSO for stock preparation.
• Loss of potency due to improper storage: Degradation occurs if the compound is stored as a solution for extended periods or exposed to moisture/heat. Only store as a solid at -20°C and prepare fresh solutions for each experiment.
• Batch variability or inconsistent inhibition: Validate each new lot using a functional assay before experimental use. If inhibition levels deviate from expected IC50 ranges, verify weighing accuracy and solvent integrity.
• Freeze-thaw cycle degradation: Avoid multiple freeze-thaw cycles of the stock solution. Prepare small aliquots as needed and discard any unused thawed material.
• Application outside validated models: Omeprazole's use is restricted to research on gastric acid secretion and antiulcer models. For other applications, confirm suitability via protocol-specific benchmarks.

Further troubleshooting strategies are detailed in Applied Use-Cases of 3-(quinolin-4-ylmethylamino)... in Gastric Models, which also covers stepwise protocols and advanced optimization tips.

Scope and Limitations

• Intended Use: This product is strictly for laboratory research use involving gastric acid secretion inhibition, antiulcer activity studies, and mechanistic modeling of gastric acid-related disorders.
• Not for Diagnostic or Medical Use: Omeprazole (A2845) is not validated for clinical, diagnostic, or therapeutic applications. Application outside the specified research scope is not supported.
• Compound Stability: Solution stability is limited; only the solid form is suitable for long-term storage. Prepare fresh DMSO stocks for each experimental series.
• Solubility Constraints: Insoluble in water and ethanol, limiting its compatibility with some aqueous-based workflows. Protocol adaptation is necessary for models requiring non-DMSO solvents.
• Model-Specific Performance: IC50 values provided are based on product specifications and may require empirical adjustment depending on the exact experimental system and assay conditions.

Conclusion

Omeprazole (SKU A2845) from APExBIO is a rigorously quality-controlled H+,K+-ATPase inhibitor, ideal for research applications requiring consistent, high-potency suppression of gastric acid secretion. Its experimentally validated IC50 values and clear solubility parameters support robust antiulcer activity studies and mechanistic exploration in gastric acid-related disease models. Adhering to recommended storage, preparation, and QC protocols will maximize reproducibility and reliability. For comprehensive workflow integration or troubleshooting, consult linked internal guides for advanced procedural insights.